Among integrins, CD103 on a CD8+ TIL subset in solid tumor correlates to favorable prognosis, and its co-expression with CD39 has been proposed as a marker for the identification of tumor-reactive CD8+ TIL [74]. This evidence concerns the gene CD8A and neoplasm.